Veeco upgraded to Overweight from Neutral at JPMorgan JPMorgan upgraded Veeco Instruments on expectations demand for MOCVDs will pick-up in 2014. The firm raised its price target for shares to $42 from $33.50.
News For VECO From The Last 14 Days
Check below for free stories on VECO the last two weeks.
Veeco Odyssey IBD upgrade supports EUV commercialization roadmap Veeco announced that its new Odyssey Ion Beam Deposition Upgrade for the NEXUS IBD-LDD System has repeatedly produced photomask blanks with zero deposition defects larger than 70 nanometers. This represents a significant milestone toward the manufacture of semiconductor devices with advanced extreme ultraviolet lithography.